E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/14/2007 in the Prospect News Bank Loan Daily and Prospect News High Yield Daily.

S&P: MedQuest, MQ on positive watch

Standard & Poor's said it placed its ratings on MedQuest Inc. and parent MQ Associates Inc. on CreditWatch with positive implications due to MedQuest's agreement to merge with Novant Health.

The agency said that Novant will pay $45 million in cash at closing, with a potential $35 million earn-out payment and that the transaction will result in a change of control under the terms of the indentures with respect to MQ Associates' $136 million face value at maturity 12¼% senior discount notes and MedQuest's $180 million 11.875% senior subordinated notes.

Affected ratings include MedQuest's corporate credit rating at B- and subordinated rating at CCC as well as MQ's corporate credit rating at B- and senior unsecured at CCC.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.